Francesco Lo-Coco

Francesco Lo-Coco

UNVERIFIED PROFILE

Are you Francesco Lo-Coco?   Register this Author

Register author
Francesco Lo-Coco

Francesco Lo-Coco

Publications by authors named "Francesco Lo-Coco"

Are you Francesco Lo-Coco?   Register this Author

100Publications

3207Reads

37Profile Views

Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders.

Biochem Pharmacol 2019 Sep 24;167:133-148. Epub 2019 Apr 24.

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2019.04.019DOI Listing
September 2019

Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome.

Leuk Res 2019 Sep 19;84:106191. Epub 2019 Jul 19.

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Fondazione Santa Lucia, Laboratorio di Neuro-Oncoematologia, Roma, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.106191DOI Listing
September 2019

The simpler, the better: oral arsenic for acute promyelocytic leukemia.

Blood 2019 Aug 21;134(7):597-605. Epub 2019 May 21.

Department of Hematology, The First Affiliated Hospital, College of Medicine, and.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood.2019000
Publisher Site
http://dx.doi.org/10.1182/blood.2019000760DOI Listing
August 2019

MRD in AML: The Role of New Techniques.

Front Oncol 2019 23;9:655. Epub 2019 Jul 23.

Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664148PMC
July 2019

Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy.

Cell Res 2019 Jun 25;29(6):446-459. Epub 2019 Apr 25.

Cancer Research Institute, Beth Israel Deaconess Cancer Center; Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41422-019-0162-7
Publisher Site
http://dx.doi.org/10.1038/s41422-019-0162-7DOI Listing
June 2019

Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.

Br J Haematol 2019 Apr 20;185(2):360-363. Epub 2018 Jul 20.

Department of Paediatric Haematology/Oncology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15507DOI Listing
April 2019

Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations.

Case Rep Hematol 2019 11;2019:6707506. Epub 2019 Apr 11.

Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/6707506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487162PMC
April 2019

PML/RARA inhibits expression of HSP90 and its target AKT.

Br J Haematol 2019 Mar 9;184(6):937-948. Epub 2018 Dec 9.

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15715DOI Listing
March 2019

Prof. Franco Mandelli: Leukaemia therapy pioneer.

Bone Marrow Transplant 2018 11 2;53(11):1375-1376. Epub 2018 Oct 2.

University Tor Vergata, Roma, Italy.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0348-5
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0348-5DOI Listing
November 2018

Molecular remission as a therapeutic objective in acute promyelocytic leukemia.

Leukemia 2018 08 19;32(8):1671-1678. Epub 2018 Jul 19.

Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0219-5DOI Listing
August 2018

Patient-reported outcome assessment in acute leukemias: Moving beyond the barriers.

Cancer 2018 07 30;124(14):3066-3067. Epub 2018 Apr 30.

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31521DOI Listing
July 2018

Towards home-based treatment for acute promyelocytic leukaemia, with caution.

Lancet Oncol 2018 07 5;19(7):846-847. Epub 2018 Jun 5.

Department of Biomedicine and Prevention, University Tor Vergata, Rome 00133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30355-3DOI Listing
July 2018

Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation.

Blood Cells Mol Dis 2018 03 21;69:57-64. Epub 2017 Sep 21.

Department of Oncology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2017.09.005DOI Listing
March 2018

Progress and criticalities in the management of acute promyelocytic leukemia.

Oncotarget 2017 Nov 12;8(59):99221-99222. Epub 2017 Nov 12.

Francesco Lo-Coco: Department of Biomedicine and prevention, University Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725086PMC
November 2017

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

N Engl J Med 2017 08 23;377(5):454-464. Epub 2017 Jun 23.

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston (R.M.S.); the Division of Biomedical Statistics and Informatics (S.J.M., K.L.) and the Alliance Statistics and Data Center (S.J.M., K.L., S.G.), Mayo Clinic, Rochester, MN; the Alliance Statistics and Data Center, Duke University, Durham, NC (B.L.S.); the Ohio State University Comprehensive Cancer Center, Columbus (S.G., C.D.B., T.W.P., G.M., R.B.K.); Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden (C.T., G.E.), Department of Internal Medicine III, University Hospital of Ulm, Ulm (K.D., R.F.S., H.D.), Hematology and Oncology, University of Leipzig, Leipzig (D.N.), Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover (J.K., A.G.), and Department of Medicine II, Hematology-Oncology, Goethe University Hospital Frankfurt, Frankfurt am Main (H.S.) - all in Germany; the Department of Biomedicine and Prevention, University Tor Vergata, Rome (F.L.-C., S.A.); the Department of Clinical Haematology, Alfred Hospital and Monash University, Melbourne, VIC, Australia (A.W.); Hospital de la Santa Creu i Sant Pau, Hematology Department, Autonomous University of Barcelona, Barcelona (J.S.), and Hospital Universitario la Fe, Hematology Department, Department of Medicine, University of Valencia, Valencia (M.A.S.) - both in Spain; the Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto (J.M.B.); Radboud Institute Molecular Studies, Radboud University Medical Center, Nijmegen, the Netherlands (T.W.); the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (F.R.A.); the Division of Hematology-Oncology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA (B.C.M.); the Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (M.S.T.); and the Department of Medicine, University of Chicago, Chicago (R.A.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1614359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754190PMC
August 2017

Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?

Blood 2017 08 10;130(7):859-866. Epub 2017 Jul 10.

Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-03-737403DOI Listing
August 2017

Very late relapse in a patient with acute promyelocytic leukemia (APL) rescued with a chemotherapy-free protocol.

Leuk Lymphoma 2017 04 23;58(4):999-1001. Epub 2016 Sep 23.

a Department of Cellular Biotechnologies and Hematology , 'Sapienza', University , Rome , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1222377DOI Listing
April 2017

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

J Clin Oncol 2017 Feb 31;35(6):605-612. Epub 2016 Oct 31.

Uwe Platzbecker, Christian Thiede, Christoph Röllig, and Gerhard Ehninger, Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden; Uwe Platzbecker and Gerhard Ehninger, Study Alliance Leukemia, Dresden; Walter Fiedler, University Hospital Hamburg-Eppendorf; Norbert Schmitz, Asklepios Klinik St Georg Hamburg, Hamburg; Peter Brossart, Innere Medizin mit deSchwerpunkten Onkologie, Haematollogie un Rheumatologie, Bonn; Bernd Hertenstein, Klinikum Bremen Mitte, Bremen; Helmut R. Salih, University Hospital Tubingen; Mohammed Wattad, Kliniken Essen Süd, Essen; Michael Lübbert, University Medical Center, Freiburg; Christian H. Brandts, Goethe University Frankfurt, Frankfurt; Mathias Hänel, Klinikum Chemnitz gGmbH, Chemnitz; Hartmut Link, Klinik für Innere Medizin I, Westpfalz-Klinikum, Kaiserslautern; Konstanze Döhner, Hartmut Döhner, and Richard F. Schlenk, University Hospital Ulm, Ulm; Arnold Ganser, Hannover Medical School, Hannover, Germany; Giuseppe Avvisati, University Campus Bio-Medico; Laura Cicconi, Mariadomenica Divona, Sergio Amadori, and Francesco Lo-Coco, University Tor Vergata; Francesca Paoloni, Marco Vignetti, Fabio Efficace, Paola Fazi, and Franco Mandelli, Gruppo Italiano Malattie Ematologiche dell'Adulto Central Office; Marco Vignetti and Massimo Breccia, Sapienza University, Rome; Felicetto Ferrara, Cardarelli Hospital, Naples; Francesco Albano, University of Bari, Bari; Marco Sborgia, U.O. di Ematologia Clinica, Pescara; Eros Di Bona, San Bortolo Hospital, Vicenza; Erika Borlenghi, U.O. di Ematologia, Spedali Civili, Brescia; Roberto Cairoli, Ospedale Niguarda, Ca' Granda, SC Ematologia; Agostino Cortelezzi, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milano; Alessandro Rambaldi, Azienda Opsedaliera Papa Giovanni XXIII, Bergamo; Lorella Melillo, Casa Sollievo della Sofferenza Hospital, IRCCS, San Giovanni Rotondo; Giorgio La Nasa, Centro Trapianti Midollo Osseo, Ospedale R. Binaghi, Università di Cagliari, Cagliari; Chiara Frairia, Hematology, Città della Salute e della Scienza, Torino; Enrico Maria Pogliani, Ospedale San Gerardo, Università degli Studi Milano Bicocca, Monza; Claudio Fozza, University of Sassari, Sassari; Alfonso Maria D'Arco, U.O. Medicina Interna e Onco-Ematologica P.O. "Umberto I," Nocera Inferiore, Nocera Inferiore; Nicola Di Renzo, Ospedale Vito Fazzi, Lecce; and Francesco Fabbiano, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.1982DOI Listing
February 2017

Trisenox: a paradigm shift in APL therapy, an interview with Francesco Lo-Coco.

Int J Hematol Oncol 2016 Nov 13;5(3):101-104. Epub 2017 Jan 13.

Department of Biomedicine & Prevention, University Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/ijh-2016-0013
Publisher Site
http://dx.doi.org/10.2217/ijh-2016-0013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171973PMC
November 2016

Panobinostat for the treatment of acute myelogenous leukemia.

Expert Opin Investig Drugs 2016 Sep 8;25(9):1117-31. Epub 2016 Aug 8.

e Department of Clinical and Experimental Medicine, Hematology Division , University of Pisa , Pisa , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2016.1216971DOI Listing
September 2016

A case of SRSF2 mutation in chronic lymphocytic leukemia.

Leuk Res Rep 2016 23;6:11-4. Epub 2016 Jun 23.

Laboratory of Neuro-Oncoematology, Santa Lucia Foundation, Rome, Italy; Department of Biomedicina e Prevenzione, "Tor Vergata" University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2016.03.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941199PMC
July 2016

Targeting of leukemia-initiating cells in acute promyelocytic leukemia.

Stem Cell Investig 2015 29;2. Epub 2015 Apr 29.

1 Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy ; 2 Department of Biomedicine and Prevention, University of Rome "Tor Vergata" and Fondazione Santa Lucia, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2306-9759.2015.04.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923659PMC
June 2016

Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.

Ann Hematol 2016 Apr 26;95(5):673-80. Epub 2016 Feb 26.

Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2622-1DOI Listing
April 2016

Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations.

Cell 2016 Apr 31;165(2):289-302. Epub 2016 Mar 31.

Cancer Research Institute, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.cell.com/cell/pdf/S0092-8674(16)30276-8.pdf
Web Search
http://www.cell.com/cms/attachment/2052247247/2059675509/mmc
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S009286741630276
Publisher Site
http://dx.doi.org/10.1016/j.cell.2016.03.020DOI Listing
April 2016

PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response.

J Hematol Oncol 2016 Apr 7;9:33. Epub 2016 Apr 7.

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0262-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823896PMC
April 2016

Current standard treatment of adult acute promyelocytic leukaemia.

Br J Haematol 2016 Mar 21;172(6):841-54. Epub 2015 Dec 21.

Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13890DOI Listing
March 2016

Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia.

Br J Haematol 2016 Mar 5;172(6):909-13. Epub 2016 Jan 5.

Department of Biomedicine and Prevention, Università di Roma "Tor Vergata", Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13910DOI Listing
March 2016

Targeted Therapy Alone for Acute Promyelocytic Leukemia.

N Engl J Med 2016 Mar;374(12):1197-8

University of Ulm, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1513710DOI Listing
March 2016

Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines.

Ann Hematol 2015 Nov 12;94(11):1807-16. Epub 2015 Aug 12.

Department of Medical, Surgical and Neurological Sciences, University of Siena, Polo Scientifico San Miniato, Via A. Moro 2, 53100, Siena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2464-2DOI Listing
November 2015

Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia.

Curr Opin Oncol 2015 Nov;27(6):532-9

aHematology, Department of Biomedicine and Prevention, Università di Roma 'Tor Vergata' bDepartment of Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000231DOI Listing
November 2015

Time to improve health-related quality of life outcomes in patients with acute promyelocytic leukemia.

Blood 2015 Nov 9;126(22):2523-4. Epub 2015 Oct 9.

Dipartimento di Biomedicina e Prevenzione, Università Tor Vergata, Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-07-658922DOI Listing
November 2015

Differential hypoxic regulation of the microRNA-146a/CXCR4 pathway in normal and leukemic monocytic cells: impact on response to chemotherapy.

Haematologica 2015 Sep 4;100(9):1160-71. Epub 2015 Jun 4.

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, University of Rome "Tor Vergata", Rome, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.120295DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800689PMC
September 2015

Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.

Nat Med 2015 May 13;21(5):457-66. Epub 2015 Apr 13.

1] Division of Translational Therapeutics, Department of Medicine, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, BIDMC, Harvard Medical School, Boston, Massachusetts, USA.. [3] Cancer Research Institute, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.3839DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425616PMC
May 2015

BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib.

Biochim Biophys Acta 2015 Mar 5;1852(3):462-72. Epub 2014 Dec 5.

Unit of Neuro-Oncohematology, Santa Lucia Foundation-I.R.C.C.S., Rome, Italy; Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2014.12.001DOI Listing
March 2015

Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia.

J Mol Diagn 2015 Mar 29;17(2):179-84. Epub 2014 Dec 29.

Department of Biomedicine and Prevention, The University Tor Vergata, Rome, Italy; Neuro-Oncohematology Unit, The Santa Lucia Foundation, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2014.10.003DOI Listing
March 2015

Reply to M. Koehler et al.

J Clin Oncol 2015 Mar 17;33(9):1091-2. Epub 2015 Feb 17.

Università Tor Vergata; Fondazione Santa Lucia, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.3597DOI Listing
March 2015

miR-21 is overexpressed in NPM1-mutant acute myeloid leukemias.

Leuk Res 2015 Feb 18;39(2):221-8. Epub 2014 Nov 18.

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.11.001DOI Listing
February 2015

Retinoic acid receptors: from molecular mechanisms to cancer therapy.

Mol Aspects Med 2015 Feb 25;41:1-115. Epub 2014 Dec 25.

Department of Medical and Surgical Sciences and Biotechnologies, University of Roma "La Sapienza", Corso della Repubblica 79, Latina I-04100. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mam.2014.12.003DOI Listing
February 2015

Outpatient oral treatment for acute promyelocytic leukemia.

N Engl J Med 2015 02;372(9):884-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1500125DOI Listing
February 2015

Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes.

J Mol Diagn 2015 Jan 24;17(1):85-9. Epub 2014 Oct 24.

Laboratory of Neuro-Oncoematology, Santa Lucia Foundation, Rome, Italy; Department of Biopathology, Tor Vergata University, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2014.08.002DOI Listing
January 2015

Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid.

Br J Haematol 2014 Nov 24;167(3):428-30. Epub 2014 Jun 24.

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12995DOI Listing
November 2014

Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes.

J Clin Oncol 2014 Oct 22;32(30):3406-12. Epub 2014 Sep 22.

Fabio Efficace, Franco Mandelli, Francesco Cottone, and Marco Vignetti, Gruppo Italiano Malattie Ematologiche dell'Adulto; Giuseppe Avvisati, Università Campus Biomedico; Massimo Breccia, Università "La Sapienza,"; Simona Sica, Università Cattolica Sacro Cuore; Sergio Amadori and Francesco Lo-Coco, Università Tor Vergata; Francesco Lo-Coco, Fondazione Santa Lucia, Roma; Felicetto Ferrara, Ospedale Cardarelli; Olimpia Finizio, Ospedale Cardarelli, Napoli; Eros Di Bona, Ospedale San Bortolo, Vicenza; Giorgina Specchia, Università di Bari, Bari; Alessandro Levis, Ospedale SS Antonio e Biagio, Alessandria; Maria Grazia Kropp, Azienda Ospedaliera Pugliese Ciaccio, Catanzaro; Giuseppe Fioritoni, Ospedale Civile, Pescara; Elisa Cerqui, Spedali Civili, Brescia, Italy; Richard F. Schlenk, University of Ulm, Ulm; and Uwe Platzbecker, Universitatsklinikum Carl Gustav Carus, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.3453DOI Listing
October 2014

What is the standard regimen for patients with acute promyelocytic leukemia?

Curr Hematol Malig Rep 2014 Jun;9(2):138-43

Department of Biomedicine and Prevention, University Tor Vergata, Via Montpellier 1, 00133, Rome, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-014-0206-5DOI Listing
June 2014

Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults.

Mediterr J Hematol Infect Dis 2014 15;6(1):e2014032. Epub 2014 Apr 15.

Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy ; Laboratory of Neuro-Oncoematology, Santa Lucia Foundation, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2014.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010611PMC
June 2014

Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.

Thromb Res 2014 May;133 Suppl 2:S112-6

Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy; Laboratory of Neuro-Oncohematology, Santa Lucia Foundation, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0049-3848(14)50019-9DOI Listing
May 2014

Understanding the molecular pathogenesis of acute promyelocytic leukemia.

Best Pract Res Clin Haematol 2014 Mar 13;27(1):3-9. Epub 2014 Apr 13.

Department of Biomedicine and Prevention, University of Rome 'Tor Vergata' and Fondazione Santa Lucia, Rome, Italy; Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.04.006DOI Listing
March 2014